Summary
Teradyne, Inc. (TER) filed a Form 8-K on October 18, 2001, primarily to disclose two significant legal matters and to reference its third-quarter 2001 financial results press release. Investors should note that the company is facing two distinct lawsuits. One, filed in California state court and subsequently moved to federal court, alleges violations of California securities statutes and breach of contract related to the acquisitions of Herco Technology Corp. and Perception Laminates, Inc. The other is a class-action lawsuit filed in Massachusetts federal court, alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 due to purported material misrepresentations and omissions regarding the company's business and future prospects during a specific period in late 2000. While the company has also released its third-quarter 2001 financial results (referenced in Exhibit 99.1), the material focus of this 8-K filing is on these legal challenges. Teradyne disputes all claims in both lawsuits and intends to defend them vigorously, stating they are without merit. The damages sought in both cases are unspecified, but include compensatory, consequential, and punitive damages, as well as attorneys' fees and costs.
Key Highlights
- 1Teradyne, Inc. filed an 8-K on October 18, 2001, reporting on significant events.
- 2The filing includes a press release (Exhibit 99.1) detailing the company's financial results for the Third Quarter of 2001.
- 3Two lawsuits are disclosed: one in California concerning acquisition-related stock sales and another class-action suit in Massachusetts alleging securities law violations (Sections 10(b) and 20(a)).
- 4The California lawsuit involves alleged violations of California securities statutes and breach of contract related to the acquisitions of Herco Technology Corp. and Perception Laminates, Inc.
- 5The Massachusetts class-action suit alleges material misrepresentations and omissions made to the investing public between July 14, 2000, and October 17, 2000.
- 6Teradyne disputes all claims in both lawsuits and states its intention to defend vigorously.
- 7Both lawsuits seek unspecified damages, including compensatory, consequential, punitive damages, and attorney's fees and costs.